Is the US prepared to deal with another pandemic or widespread health crisis?

No, the US is not fully prepared for another pandemic or major widespread health crisis, though it is better equipped in some areas (e.g., stockpiles and certain surveillance tools) than before COVID-19. Significant structural, funding, coordination, workforce, and political vulnerabilities remain, and recent policy shifts have raised concerns about backsliding.[1][2]

Assessments from bipartisan experts, government watchdogs, CDC testimony, and international bodies consistently highlight progress mixed with persistent gaps. A severe respiratory pandemic, novel pathogen, or multi-threat scenario (e.g., combined with antimicrobial resistance or climate-driven outbreaks) would still strain systems heavily.

Improvements Since COVID-19

•Strategic National Stockpile (SNS): Substantially restocked. Compared to pre-pandemic levels, it held roughly 70 times more N95 respirators, 34 times more gloves, 50 times more isolation gowns, and 10 times more ventilators (per Biden administration reports around early 2025). It has supported responses to H5N1, mpox, and other incidents with PPE, antivirals, and vaccines. Domestic manufacturing investments and vendor-managed inventory helped.[3][4]

•Surveillance and Data: Electronic case reporting expanded from fewer than 200 healthcare facilities in 2020 to over 45,000–48,000 by late 2024. Syndromic surveillance covers most hospital EDs. Wastewater monitoring, forecasting/modeling (e.g., CDC’s Center for Forecasting and Outbreak Analytics), and platforms for real-time data sharing improved detection. CDC has pursued “warm base” partnerships with clinical labs for rapid test development/surge capacity.[5][3]

•Medical Countermeasures and R&D: BARDA and related efforts advanced vaccines, therapeutics, and diagnostics (dozens of approvals). Investments supported mRNA platforms adaptable to new threats (e.g., H5N1 candidates) and domestic production. Lessons improved testing quality control and supply chain visibility.[6]

•Coordination Structures: The Office of Pandemic Preparedness and Response Policy (OPPR) was established in 2023 as a White House coordinating body. Playbooks, National Biodefense Strategy updates, and Global Health Security efforts advanced under prior administrations. CDC reorganized toward more integrated, disease-agnostic response capabilities.[3]

•Global Engagement (prior): Contributions to the Pandemic Fund, vaccine sharing, and capacity-building in partner countries aimed to stop threats abroad.

These built on COVID-era surges in testing, vaccination infrastructure, and emergency authorities.

Persistent and Emerging Gaps

•Leadership, Coordination, and Implementation: The Bipartisan Commission on Biodefense’s 2024 National Blueprint stated the biological threat is “real and growing” and the nation remains “dangerously vulnerable,” with fragmented efforts insufficient despite years of recommendations. Many prior Commission and GAO suggestions went unimplemented. GAO reported roughly half of its ~400+ COVID-related recommendations to agencies remained open as of mid-to-late 2024 (e.g., on HHS leadership/coordination of emergencies—a high-risk area—supply chains, testing strategies, data systems, and workforce). Clear roles, interoperable biosurveillance networks (statutorily required for years), and consistent guidance remain challenges.[1][2][7]

•Workforce and Public Health Infrastructure: Chronic underfunding and losses (pre-COVID declines of ~13% in some areas) left state/local/tribal/territorial agencies strained. COVID exposed burnout and surge difficulties; sustained investments have been uneven. Core capabilities (labs, data analytics, readiness) need ongoing resources and authorities.[5]

•Supply Chains and Equity: Just-in-time models, foreign dependencies, and visibility gaps caused early COVID shortages. While stockpiles grew and some domestic capacity returned, vulnerabilities persist for novel countermeasures, raw materials, and equitable distribution. Access for underserved groups and trust erosion (from politicization and communication issues) hinder response.

•Funding Sustainability: Supplemental COVID funds expired or were rescinded; base budgets for preparedness have not fully matched needs or risk. Programs like temporary vaccine access bridges ended early. Global contributions face hurdles.

•Recent Developments (2025–2026 context): Reports indicate the OPPR was largely emptied after the prior administration’s staff departed, then minimally restaffed (e.g., a couple of personnel amid outbreaks of measles, hantavirus, Ebola, and others). Criticisms include cuts or shifts at CDC/NIH affecting surveillance databases, biodefense R&D priorities, and global health security (e.g., USAID restructuring, WHO withdrawal, reduced emphasis on certain multilateral efforts like the Pandemic Fund/CEPI in some requests). ASPR continues MCM work and exercises, but experts (including former officials) warn of weakened detection/response capacity. The Global Preparedness Monitoring Board’s 2026 report found the world not meaningfully safer—outbreaks more frequent/damaging, investments lagging risk, equity and recovery capacity worsening—amid geopolitical fragmentation and eroding trust.[8][9][10][11]

•Other Risks: H5N1 (avian flu) spillover monitoring continues with stockpiled vaccines, but human adaptation risk persists. Novel or engineered threats, antimicrobial resistance, and multi-hazard events (pandemic + climate/weather) test resilience. Public trust and consistent messaging remain fragile.

Overall Assessment

The US has stronger physical stockpiles, some modernized data/lab tools, and hard-won operational experience than in 2019. It can likely handle moderate outbreaks or localized surges better (as seen in recent mpox/H5N1/Ebola support). However, it is not adequately prepared for a high-severity, fast-spreading pandemic comparable to or worse than COVID-19. Key weaknesses include incomplete implementation of lessons (per GAO and the Biodefense Commission), fragile funding/workforce, coordination shortfalls, supply chain risks, and recent reductions in dedicated pandemic architecture and international partnerships.[1][2]

Experts emphasize that pandemics are inevitable (probability estimates for major events in coming decades are substantial), and prevention/early detection abroad plus rapid domestic surge are critical. Sustained bipartisan investment in core public health, clear leadership (e.g., empowered OPPR-like functions), domestic manufacturing resilience, transparent data-sharing, workforce rebuilding, and international cooperation would close gaps. Without them, another crisis risks high excess mortality, economic disruption, and eroded confidence—echoing COVID’s >1 million US deaths. Continuous monitoring via tools like CDC’s IRAT (for flu risks) and exercises helps, but structural fixes are essential.

Citations (11)

1biodefensecommission.orgNonprofits and think tanks
https://biodefensecommission.org/reports/the-national-blueprint-for-biodefense/
Backs: “Significant structural, funding, coordination, workforce, and political vulnerabilities remain, and recent policy shifts have raised concerns about backsliding.”
2stimson.orgNonprofits and think tanks
https://www.stimson.org/2024/prepare-for-the-next-biothreat-now/
Backs: “Significant structural, funding, coordination, workforce, and political vulnerabilities remain, and recent policy shifts have raised concerns about backsliding.”
3archives.govGovernment
https://bidenwhitehouse.archives.gov/briefing-room/statements-releases/2025/01/14/report-the-biden-harris-administration-roadmap-for-pandemic-preparedness-and-response/
Backs: “Domestic manufacturing investments and vendor-managed inventory helped.”
4politifact.comNews and mediaquality 0.87
https://www.politifact.com/truth-o-meter/promises/biden-promise-tracker/promise/1556/rebuild-health-stockpiles-be-ready-crises/article/3033/
Backs: “Domestic manufacturing investments and vendor-managed inventory helped.”
5cdc.govGovernment
https://www.cdc.gov/washington/testimony/2024/t20241114.htm
Backs: “CDC has pursued “warm base” partnerships with clinical labs for rapid test development/surge capacity.”
6aspr.govGovernment
https://www.aspr.gov/news-updates/blog/2025-12/stand-ready-move-fast-save-lives
Backs: “Lessons improved testing quality control and supply chain visibility.”
7gao.govGovernment
https://www.gao.gov/products/gao-24-107175
Backs: “Clear roles, interoperable biosurveillance networks (statutorily required for years), and consistent guidance remain challenges.”
8notus.orgNot yet classified
https://www.notus.org/health-science/white-house-pandemic-preparedness
Backs: “The Global Preparedness Monitoring Board’s 2026 report found the world not meaningfully safer—outbreaks more frequent/damaging, investments lagging risk, equity and recovery capacity worsening—amid geopolitical fragmentation and eroding trust.”
9scientificamerican.comNews and mediaquality 0.86
https://www.scientificamerican.com/article/the-world-is-less-prepared-for-a-pandemic-than-before-covid-heres-why/
Backs: “The Global Preparedness Monitoring Board’s 2026 report found the world not meaningfully safer—outbreaks more frequent/damaging, investments lagging risk, equity and recovery capacity worsening—amid geopolitical fragmentation and eroding trust.”
10justthenews.comNews and mediaquality 0.57
https://justthenews.com/government/white-house/after-outbreaks-trump-admin-restarts-office-pandemic-preparedness-and
Backs: “The Global Preparedness Monitoring Board’s 2026 report found the world not meaningfully safer—outbreaks more frequent/damaging, investments lagging risk, equity and recovery capacity worsening—amid geopolitical fragmentation and eroding trust.”
11gpmb.orgNot yet classified
https://gpmb.org/reports/m/item/a-world-on-the-edge-2026-report
Backs: “The Global Preparedness Monitoring Board’s 2026 report found the world not meaningfully safer—outbreaks more frequent/damaging, investments lagging risk, equity and recovery capacity worsening—amid geopolitical fragmentation and eroding trust.”